Mesa Laboratories Inc. (MLAB)
NASDAQ: MLABIndustrialsIndustrial Machinery/ComponentsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
MLAB stock chart
Technical analysisKey statistics
All statistics- Market cap
- $719.03M
- P/E (TTM)
- 110.28
- Forward P/E
- 10.51
- EPS (TTM)
- $1.16
- Dividend yield
- 0.50% ($0.64)
- Ex-dividend date
- Nov 30, 2026
- 52-week range
- 70.19 – 144.35
- Day range
- 126.73 – 133.85
- Volume / Avg
- 76.01K / 115.00K
- Beta
- —
- Shares outstanding
- 5.62M
52-week range
MLAB stock today
Shares of Mesa Laboratories (MLAB) finished lower on Nov 20 at $127.93, a drop of 4.11% or $5.48 per share, versus the S&P 500's 3.70% decline. At this level, MLAB sits in the middle of its 52-week range of $70.19 to $144.35: 11.4% below the high, set on Oct 6, 2026 and 82.3% above the low. MLAB is up 63.0% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 81.2%.
At 110.3x trailing earnings, Mesa Laboratories trades above the peer-group median of 34.2x. Its forward P/E of 10.5x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. To receive the next $0.16 dividend, investors must own shares before the Nov 30 ex-dividend date.
Summary generated from market data by MetaCap's automated system. Methodology
About Mesa Laboratories
Company profileMesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.
- Sector
- Industrials
- Industry
- Industrial Machinery/Components
- CEO
- Dr. Siddhartha Chandrakant Kadia B.E., M.S., Ph.D.
- Headquarters
- Lakewood, CO
- Employees
- 717
- Website
- mesalabs.com
Financial highlights
Full financialsIn fiscal 2026, Mesa Laboratories generated $249.1 million in revenue, up 3.4% from fiscal 2025, its 2nd consecutive year of revenue growth. Net income was $6.7 million, for a net margin of 2.7% versus a median of 0.4% in the prior 5 years. Gross margin was 63.5% (up from 62.6%) and operating margin 7.4%.
| Fiscal year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Revenue | $249.13M | $240.98M | $216.19M | $219.08M | $184.34M |
| Growth | +3.38% | +11.47% | -1.32% | +18.85% | +37.63% |
| Net income | $6.71M | $-1.97M | $-254.25M | $930.00K | $1.87M |
| EPS (diluted) | $1.21 | $-0.36 | $-47.20 | $0.17 | $0.35 |
Analyst forecast
ForecastConsensus (2 analysts)
buy
Avg. price target
$150.00+17.25%
- Strong buy 0
- Buy 1
- Hold 1
- Sell 0
- Strong sell 0
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 9, 2026
- EPS actual vs est.
- $1.22 vs —
Dividends
Dividend history- Annual dividend
- $0.64
- Dividend yield
- 0.50%
- Last payment
- $0.16
- Ex-dividend date
- Nov 30, 2026
- Pay date
- Dec 15, 2026
MLAB news
All MLAB news- Mesa Laboratories, Inc. Reports Second Quarter Fiscal Year 2027 Results and Issues Full-Year GuidanceNasdaqMLAB, MKC.V
- Mesa Labs (MLAB) Q2 2027 Earnings Call TranscriptNasdaqMLAB, ET
- Mesa Laboratories GAAP EPS of $0.75 beats by $0.39, revenue of $62.3M beats by $0.1MSeeking Alpha
- Mesa Labs Announces Second Quarter Fiscal Year 2027 Results and Issues First Full-Year GuidanceGlobeNewswire
- Mesa Labs Announces Second Quarter Financial Results Release Date and Earnings Conference CallGlobeNewswire
- Mesa Laboratories announces $9.3M cost-savings planSeeking Alpha
- Mesa Laboratories To Cut 40 Jobs, Plan $9.3 Mln Cost SavingsNasdaq
- Mesa Laboratories Announces Restructuring and Savings Plan to Reduce Annualized Costs by Approximately $9.3 Million and Reinvest Approximately $4.3 Million in Profitable GrowthGlobeNewswire
Mesa Laboratories peers
Industrials sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| NANOForge Nano Holdings Inc. | 3.04 | -2.56% | $682.26M | vs MLAB |
| FLNCFluence Energy Inc. Class A | 3.46 | -9.66% | $673.53M | vs MLAB |
| KODKEastman Kodak Company Common New | 7.81 | -2.13% | $766.16M | vs MLAB |
| VREXVarex Imaging Corporation | 18.10 | -0.22% | $768.59M | vs MLAB |
| PSIXPower Solutions International Inc. | 28.27 | -11.02% | $652.06M | vs MLAB |
| KRNTKornit Digital Ltd. | 14.60 | -1.02% | $627.31M | vs MLAB |
| GHMGraham Corporation | 69.94 | -9.56% | $820.95M | vs MLAB |
| AMPXAmprius Technologies Inc. | 5.77 | -9.84% | $846.13M | vs MLAB |
Indexes, lists and sector
Mesa Laboratories stock FAQ
What is Mesa Laboratories's stock price today?
MLAB last traded at $127.93 as of Nov 20, 4:00 PM EST, down 4.11% on the day. Prices are delayed at least 15 minutes.
Does Mesa Laboratories pay a dividend?
Yes. Mesa Laboratories pays $0.64 per share annually, a 0.50% yield. The most recent dividend of $0.16 had an ex-dividend date of Nov 30, 2026.
What is MLAB's P/E ratio?
MLAB trades at a trailing P/E ratio of 110.28 and a forward P/E of 10.51, compared with a median of 34.2 for its closest peers.
Who is Mesa Laboratories's CEO?
Dr. Siddhartha Chandrakant Kadia B.E., M.S., Ph.D. is the chief executive officer of Mesa Laboratories Inc., which has about 717 employees.
What is the MLAB 52-week high?
The 52-week high for MLAB is $144.35 and the 52-week low is $70.19. The stock is currently 11.4% below its high.